London (PRWEB) September 17, 2013
New study reveals sales potential of this large, expanding market
See what the future holds for painkillers. Visiongain's report gives you revenue predictions to 2023. You find data, trends, opportunities and commercial prospects.
That new study lets you assess forecasted sales at overall world market, submarket, product and national level. You see why the pain relievers industry and market will grow, as we predict.
In our investigation you find revenue forecasting, growth rates and market shares. Also, you see qualitative analyses, R&D and commercial developments. You receive 84 tables, 79 charts and three research interviews.
The following sections highlight what you discover in the report.
Prospects for submarkets and products
In addition to analyses of the overall world market, you see revenue forecasting of five world-level submarkets to 2023:
Also, you see how 29 leading drugs - including Oxycontin ER, Panadol, Lyrica and Zomig - can perform to 2023. Our study includes OTC (over-the-counter) and Rx (prescription) pain relieving medicines. There, you find revenue forecasts and other data.
The work also breaks the overall world market into leading national markets.
Prospects for leading countries shown to 2023
Developments worldwide will influence the market, especially fast-rising demand in emerging countries. There will be many opportunities for pain-treating products.
You discover revenue forecasts to 2023 for twelve national markets:
Copyright©2012 Vocus, Inc.
All rights reserved